Next Generation Sequencers: Global Strategic Business Report

Report
299 Pages
April 2024
Region: Global
Global Industry Analysts, Inc
ID: 2228053

Global Next Generation Sequencers Market to Reach $29.6 Billion by 2030

The global market for Next Generation Sequencers estimated at US$7.7 Billion in the year 2022, is projected to reach a revised size of US$29.6 Billion by 2030, growing at a CAGR of 18.4% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 20.7% CAGR and reach US$40.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Platforms segment is readjusted to a revised 15.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 25.9% CAGR

The Next Generation Sequencers market in the U.S. is estimated at US$2.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$8.1 Billion by the year 2030 trailing a CAGR of 25.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.5% and 14.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.2% CAGR.

Select Competitors (Total 93 Featured) -

Agilent Technologies, Inc.
Becton, Dickinson and Company
Fluidigm Corporation
Illumina Inc.
Oxford Gene Technology
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN N.V.
RainDance Technologies Inc.
Roche Sequencing
Thermo Fischer Scientific Inc.

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Next Generation Sequencing Techniques Transform the Genomics Space
Recent Market Activity
Next Generation Sequencers (NGS): A High-Throughput Sequencing Technology
US Leads the NGS Market, Asia-Pacific to Foster Future Growth
Academic & Research Dominates NGS Market
Oncology Testing - The Application with Most Promising Opportunities for NGS Technology
Declining Cost of Sequencing to Fuel Adoption of NGS Systems
After Dramatic Price Declines, Is NGS Market Positioned for Further Disruption?
Next Generation Sequencers - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

Agilent Technologies Inc. (US)
Becton, Dickinson and Company (BD) (US)
Fluidigm Corporation (US)
Genomatix GmbH (Germany)
Illumina, Inc. (US)
Oxford Gene Technology (UK)
Oxford Nanopore Technologies (UK)
Pacific Biosciences of California, Inc. (US)
QIAGEN N.V. (The Netherlands)
RainDance Technologies, Inc. (US)
Roche Sequencing (US)
Shenzhen BGI Diagnosis Co., Ltd. (China)
Thermo Fisher Scientific, Inc. (US)

3. MARKET TRENDS & DRIVERS

Expanding Applications of NGS Technology
NGS Revolutionizes Drug Discovery and Development Space
Genetic Information offered by NGS Aids in Drug Development Process
Revolutionary Capabilities of NGS Technology to Play a Vital Part in Advancement of Precision Medicine
Rising Incidences of Cancer & Benefits of Personalized Cancer Therapy to Propel NGS Market
Comparison of Sanger Sequencing, Real-time PCR Sequencing and Next Generation Sequencing Methods for Identification of Driver Mutations
Key Cancer Statistics
NGS Emerges as a Game Changing Technology for Precision Oncology
Personalized Medicine: Growing Prominence of NGS in Providing Customized Treatments to Patients
Growing Significance of NGS in Enabling Personalized Oncology - Timeline of Major Developments in Sequencing Technologies & Applications Related to Oncology
Personal Genomics Services - Blessing or Bane?
NGS Technology Drives RNA Sequencing in Transcriptomics
Longer Reach of a Read: A Key Feature Considered for Sequencing
qPCR - The Core Technique in NGS Technique
Development of New Systems & Platforms to Fuel NGS Utilization
Advancements in Next Generation Sequencing (NGS) Technology Fuel Adoption
Development Efforts Intensify in Long-Read Sequencing
Single-Cell Genomics: A Promising Application of NGS Technology
Shift from Tumor Biopsies to Cancer Liquid Biopsies
NGS Enhances Study of Antimicrobial Resistance
Effective Use of NGS Tools in Public Healthcare Systems
E-Infrastructure for Storage & Analysis of NGS Data
Explosive Growth in Sequencing Data Drives Focus onto Cloud Computing
NGS Hold an Edge Over CE Sequencing Method
Standardization of NGS Technique: A Critical Requirement for Wider Adoption
Challenges Confronting High-throughput Sequencing Market
High Machine Costs and Licensure Fees
Lack of Skilled Personnel
Absence of Regulatory Framework
Limited Access to Scientific Literature and Internet
Suboptimal Outsourcing Services
Regulations Related to NGS-Based Tests
Innovative Technologies
Nanopore Sequence Technology
Single-Molecule Real-Time technology (SMRT)
Direct Genomics’ Single Molecule Sequencing
TruSPADES Simplifies Metagenomics Sequencing
GnuBIO Platform
Electron Microscopy DNA Sequencing
FRET-based DNA Sequencing
Identification/Sequencing using Mechanical Properties
MALDI-TOF MS
RNAP Sequencing Method
Tunneling Currents DNA Sequencing
qPCR-Driven Library Quantitation Saves Time and Overheads
Achieving Trans-Block Uniformity
Enhancing qPCR Precision

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Current & Future Analysis for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Biomarkers & Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Biomarkers & Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Biomarkers & Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)

CANADA

JAPAN

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)

CHINA

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)

EUROPE

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)

FRANCE

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)

GERMANY

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)

ITALY

UNITED KINGDOM

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)

SPAINRUSSIAREST OF EUROPE

ASIA-PACIFIC

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)

AUSTRALIA

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)

INDIA

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)

SOUTH KOREAREST OF ASIA-PACIFIC

LATIN AMERICA

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)

ARGENTINABRAZILMEXICOREST OF LATIN AMERICA

MIDDLE EAST

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)

IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST

AFRICA

Next Generation Sequencers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Agilent Technologies, Inc.
Becton, Dickinson and Company
Fluidigm Corporation
Illumina Inc.
Oxford Gene Technology
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN N.V.
RainDance Technologies Inc.
Roche Sequencing
Thermo Fischer Scientific Inc.

Table Information

Report Attribute	Details
No. of Pages	299
Published	April 2024
Forecast Period	2020 - 2027
Estimated Market Value ( USD ) in 2020	$ 5.3 Billion
Forecasted Market Value ( USD ) by 2027	$ 37.2 Billion
Compound Annual Growth Rate	32.1%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5282EUR$5,450USD£4,524GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10035EUR$10,355USD£8,595GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15845EUR$16,350USD£13,571GBP

Global Next Generation Sequencers Market to Reach $29.6 Billion by 2030

The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 25.9% CAGR

Select Competitors (Total 93 Featured) -

What's New?

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Next Generation Sequencers Market - Forecasts from 2023 to 2028

Next Generation Sequencers Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Next Generation Sequencing Market by Offering Type Application Technology - Global Forecast to 2030

Global Next Generation Sequencing Sample Preparation Market Analysis & Forecast to 2024-2034

Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2024-2032

About the Next Generation Sequencer Market